Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Acquisitions (2015 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Acquisitions of -$2.32 million for fiscal Q1 2027 (quarter ended Jun 30, 2026).

Analysis

Dr Reddys Laboratories (RDY) Acquisitions (2015 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories posted Acquisitions of $34 million, down 94.5% from FY2025.

  • Acquisitions has a five-year compound annual growth rate of -30.7% (FY2021 to FY2026).
  • By fiscal year, Acquisitions came in at $622 million in FY2025 and $4 million in FY2022 (-98.1%).
  • The fiscal Q1 2027 figure ranks as the highest quarterly Acquisitions since fiscal Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -17.15 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 10.59 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.32 Mn
Mar 31, 2021 425.55 Mn
Sep 30, 2020 -7.04 Mn
Jun 30, 2020 -197.13 Mn
Mar 31, 2016 235.29 Mn
Jun 30, 2015 -125.31 Mn
API Access

Dr Reddys Laboratories Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=RDY&period=max&api_key=YOUR_API_KEY